Evidence map›Paper›PMID 38787229›Full record

ArticlePathogens (Basel, Switzerland)2024

Polio Surge Capacity Support Program Contributions to Building Country Capacities in Support of Polio Outbreak Preparedness and Response: Lessons Learned and Remaining Challenges.

Fikru Abebe, Victor Anochieboh Eboh, Mesfin Belew Weldetsadik, Ibrahima Kone, Tessema Assegid Kebede, Paul Thomas Harries, Veh Kesse Fabien Diomande

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fikru AbebePolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Victor Anochieboh EbohPolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Mesfin Belew WeldetsadikPolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Ibrahima KonePolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Tessema Assegid KebedePolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Paul Thomas HarriesGlobal Security Department (GSD), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.
Veh Kesse Fabien DiomandePolio Surge Capacity Support Program, Center for Vaccine Equity (CVE), The Task Force for Global Health (TFGH), Decatur, GA 30030, USA.

Funding

CDC HHS
6 · The paper itself

Abstract

Despite coordinated efforts at global level, through the Global Polio Eradication Initiative (GPEI), poliomyelitis disease (Polio) is still a major public health issue. The wild poliovirus type-1 (WPV1) is still endemic in Afghanistan and Pakistan, and new circulations of the WPV1 were confirmed in southeast Africa in 2021, in Malawi and Mozambique. The circulating vaccine derived polioviruses (cVDPV) are also causing outbreaks worldwide. The Task Force for Global Health (TFGH)'s Polio Surge Capacity Support Program, established in 2019, is an effort to reinforce the existing partnership with the GPEI to strengthen countries' capacities for polio outbreak preparedness and response. In four years, its coordinated efforts with GPEI partners have resulted in a remarkable improvement in the early detection of poliovirus circulation and reducing the missed children gaps in many countries. However, these encouraging results cannot hide an increasingly complex programmatic environment with numerous funding and operational challenges.

Indexed as

Disease OutbreaksGlobal HealthPoliomyelitisCapacity BuildingDisease EradicationHumansImmunization ProgramsPoliovirusPoliovirus VaccinesSurge CapacityPoliovirus Vaccinescampaignchildrenpartnershippoliovirussurveillancevaccine

Identifiers

PMID38787229
PMCPMC11123817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.